Add Notes

        
AN ACT

        ENTITLED, An Act to  revise the schedule of certain controlled substances.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA:
     Section  1.  That § 34-20B-12 be amended to read as follows:
     34-20B-12.   Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule I, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
             (1)      Acetylmethadol;
             (2)      Allylprodine;
             (3)      Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM;
             (4)      Alphameprodine;
             (5)      Alphamethadol;
             (6)      Benzethidine;
             (7)      Betacetylmethadol;
             (8)      Betameprodine;
             (9)      Betamethadol;
             (10)      Betaprodine;
             (11)      Clonitazene;
             (12)      Dextromoramide;
             (13)      Diampromide;
             (14)      Diethyliambutene;
             (15)      Dimenoxadol;
             (16)      Dimepheptanol;
             (17)      Dimethyliambutene;
             (18)      Dioxaphetyl butyrate;
             (19)      Dipipanone;
             (20)      Ethylmethylthiambutene;
             (21)      Etonitazene;
             (22)      Etoxeridine;
             (23)      Furethidine;
             (24)      Hydroxypethidine;
             (25)      Ketobemidone;
             (26)      Levomoramide;
             (27)      Levophenacylmorphan;
             (28)      Mecloqualone;
             (29)      Morpheridine;
             (30)      Noracymethadol;
             (31)      Norlevorphanol;
             (32)      Normethadone;
             (33)      Norpipanone;
             (34)      Phenadoxone;
             (35)      Phenampromide;
             (36)      Phenomorphan;
             (37)      Phenoperidine;
             (38)      Piritramide;
             (39)      Proheptazine;
             (40)      Properidine;
             (41)      Racemoramide;
             (42)      Trimeperidine;
             (43)      Methaqualone;
             (44)    N-benzylpiperazine.
     Section  2.  That § 34-20B-14 be amended to read as follows:
     34-20B-14.   Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, is included in Schedule I, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
             (1)      Bufotenine;
             (2)      Diethyltryptamine;
             (3)      Dimethyltryptamine;
             (4)      5-methoxy-N, N-Dimethyltryptamine;
             (5)      5-methoxy-3, 4-methylenedioxy amphetamine;
             (6)      4-bromo-2, 5-dimethoxyamphetamine;
             (7)      4-methoxyamphetamine;
             (8)      4-methoxymethamphetamine;
             (9)      4-methyl-2, 5-dimethoxyamphetamine;
             (10)      Hashish and hash oil;
             (11)      Ibogaine;
             (12)      Lysergic acid diethylamide;
             (13)      Mescaline;
             (14)      N-ethyl-3-piperidyl benzilate;
             (15)      N-methyl-3-piperidyl benzilate;
             (16)      1-(-(2-thienyl)cyclohexyl) piperdine;
             (17)      Peyote, except that when used as a sacramental in services of the Native American church in a natural state which is unaltered except for drying or curing and cutting or slicing, it is hereby excepted.;
             (18)      Psilocybin;
             (19)      Psilocyn;
             (20)      Tetrahydrocannabinol, other than that which occurs in marijuana in its natural and unaltered state;
             (21)      3, 4, 5-trimethoxy amphetamine;
             (22)      3, 4-methylenedioxy amphetamine;
             (23)      3-methoxyamphetamine;
             (24)      2, 5-dimethoxyamphetamine;
             (25)      2-methoxyamphetamine;
             (26)      2-methoxymethamphetamine;
             (27)      3-methoxymethamphetamine;
             (28)      Phencyclidine;
             (29)      3, 4-methylenedioxymethamphetamine (MDMA);
             (30)      3, 4-methylenedioxy-N-ethylamphetamine;
             (31)      N-hydroxy-3, 4-methylenedioxyamphetamine;
             (32)      4-methylaminorex (also known as 2-Amino-4-methyl/x-5-phenyl-2-oxazoline);
             (33)      2,5 Dimethoxy-4-ethylamphetamine;
             (34)      N,N-Dimethylamphetamine;
             (35)      1-(1-(2-thienyl)cyclohexyl)pyrrolidine;
             (36)      Aminorex;
             (37)      Cathinone;
             (38)      Methcathinone;
             (39)      2,5-Dimethoxy-4-ethylamphetamine (DOET);
             (40)      Alpha-ethyltryptamine;
             (41)      4-Bromo-2,5-dimethoxy phenethylamine;
             (42)    2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7);
             (43)    1-(3-trifluoromethylphenyl) piperazine (TFMPP).
     Section  3.  That § 34-20B-20 be amended to read as follows:
     34-20B-20.   Any material, compound, mixture, or preparation is included in Schedule III which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:
             (1)      Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules;
             (2)      Chloral betaine;
             (3)      Chloral hydrate;
             (4)      Chlorhexadol;
             (5)      Lysergic acid;
             (6)      Lysergic acid amide;
             (7)      Methyprylon;
             (8)      Sulfondiethylmethane;
             (9)      Sulfonethylmethane;
             (10)      Sulfonmethane;
             (11)      Amobarbital, pentobarbital, and secobarbital in suppository dosage form;
             (12)      Gamma hydroxy butyrate;
             (13)      Dronabinol;
             (14)    Buprenorphine.
     Section  4.  That § 34-20B-25 be amended to read as follows:
     34-20B-25.   The following are included in Schedule IV:
             (1)      Chlordiazepoxide, but not including librax (chlordiazepoxide hydrochloride and clindinium bromide) or menrium (chlordiazepoxide and water soluble esterified estrogens);
             (2)      Clonazepam;
             (3)      Clorazepate;
             (4)      Diazepam;
             (4A)      Flunitrazepam;
             (5)      Flurazepam;
             (6)      Mebutamate;
             (7)      Oxazepam;
             (8)      Prazepam;
             (9)      Lorazepam;
             (10)      Triazolam;
             (11)      Any substance which contains any quantity of a benzodiazepine, or salt of benzodiazepine, except those substances which are specifically listed in other schedules;
             (12)     
             (13)      Cathine;
             (14)      Fencamfamine;
             (15)      Fenproporex;
             (16)      Mefenorex;
             (17)      Pyrovalerone;
             (18)      Propoxyphene;
             (19)      Pentazocine;
             (20)      Diethylpropion;
             (21)      Ethchlorvynol;
             (22)      Ethinamate;
             (23)      Fenfluramine;
             (24)      Mazindol;
             (25)      Mephobarbital;
             (26)      Methohexitol;
             (27)      Paraldehyde;
             (28)      Pemoline;
             (29)      Petrichloral;
             (30)      Phentermine;
             (31)      Barbital;
             (32)      Phenobarbital;
             (33)      Meprobamate;
             (34)      Zolpidem;
             (35)      Butorphanol;
             (36)      Modafinil, including its salts, isomers, and salts of isomers;
             (37)      Sibutramine;
             (38)      Zaleplon;
             (39)      Dichloralphenazone.
An Act to revise the schedule of certain controlled substances.

=========================
I certify that the attached Act originated in the

SENATE as Bill No. 25

____________________________
Secretary of the Senate
=========================     

____________________________
President of the Senate

Attest:

____________________________
Secretary of the Senate

____________________________
Speaker of the House

Attest:

____________________________
Chief Clerk

Senate Bill No. 25
File No. ____
Chapter No. ______  
  =========================
Received at this Executive Office this _____ day of _____________ ,

20____ at ____________ M.


By _________________________
for the Governor
=========================

The attached Act is hereby approved this ________ day of ______________ , A.D., 20___

____________________________
Governor
=========================
STATE OF SOUTH DAKOTA,
ss.
Office of the Secretary of State

Filed ____________ , 20___
at _________ o'clock __ M.

____________________________
Secretary of State

By _________________________
Asst. Secretary of State